Real-World Data Confirm Immunotherapy Boost for Aggressive Early Breast Cancer
A real-world study of 95 patients in Tokyo confirms that pembrolizumab combined with chemotherapy before and after surgery delivers event-free ...
A real-world study of 95 patients in Tokyo confirms that pembrolizumab combined with chemotherapy before and after surgery delivers event-free ...
A new review synthesizes declining contralateral breast cancer incidence, evolving risk prediction models, the biology of second primary tumors, and ...
Surgeons in Palestine report successfully rebuilding an infected, ulcerated armpit defect with a latissimus dorsi muscle flap ten years after ...
Breast cancer remains one of the most challenging diseases in oncology, in part due to its capacity for late recurrence. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine